Hyperspectral Drusen Classification

CompletedOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

November 8, 2022

Primary Completion Date

August 15, 2023

Study Completion Date

August 15, 2023

Conditions
Dry Age Related Macular Degeneration
Interventions
DEVICE

Mydriatic Hyperspectral retinal Camera, (MHRC) and Optical coherence tomography (OCT)

Imaging with the MHRC and optical coherence tomography (OCT).

Trial Locations (1)

H3H 1G6

Clinique Ophtalmologique 2121, Montreal

Sponsors
All Listed Sponsors
lead

Optina Diagnostics Inc.

INDUSTRY

NCT06860555 - Hyperspectral Drusen Classification | Biotech Hunter | Biotech Hunter